Cambridge Investment Research Advisors, Inc. Trevena Inc Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 17, 2022
BUY
$0.16 - $100.0 $14,380 - $8.99 Million
89,880 Added 136.48%
155,738 $0
Q2 2022

Jul 13, 2022
BUY
$0.2 - $0.5 $7,526 - $18,816
37,633 Added 133.33%
65,858 $27,000
Q1 2022

May 12, 2022
BUY
$0.41 - $0.63 $11,572 - $17,781
28,225 New
28,225 $15,000

About TREVENA INC

TRVN Quotes by TradingView
  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $292M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email